Advertisement

Illicit and Counterfeit Drug Analysis by Morphologically Directed Raman Spectroscopy

  • Andrew C. Koutrakos
  • Pauline E. Leary
  • Brooke W. KammrathEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1810)

Abstract

Morphologically directed Raman spectroscopy (MDRS) is a novel tool for the forensic analysis of illicit and counterfeit drug samples. MDRS combines Raman microspectroscopy with automated particle imaging so that physical and chemical information about the components of a mixture sample can be obtained. Results of automated particle imaging are used to determine samples for Raman analysis. The use of MDRS for these types of samples can be employed for both forensic investigations and adjudications of cases. The method provides insight about the physical and chemical composition of the sample, as well as about manufacturing and sample history. Here, MDRS was used in four different illicit and counterfeit drug analyses: (1) examination of a multicomponent drug mixture where the results could be used for comparative source attribution, (2) the detection of low (or trace) concentration particles in a drug sample, (3) the analysis of synthetic cathinone samples (i.e., bath salts), and (4) a study of counterfeit pharmaceutical products.

Key words

Morphologically directed Raman spectroscopy Illicit drug analysis Counterfeit pharmaceuticals Raman spectroscopy Automated particle imaging 

References

  1. 1.
    Martin A, Swarbrick J, Cammarata A (1983) Physical pharmacy: physical chemical principles in the pharmaceutical sciences, 3rd edn. Lea & Febiger, Philadephia, PAGoogle Scholar
  2. 2.
    Iranloye TA, Parrott EL (1978) Effects of compression force, particle size, and lubricants on dissolution rate. J Pharm Sci 67(4):535–539CrossRefPubMedGoogle Scholar
  3. 3.
    Dunne M, Corrigan OI, Ramtoola Z (2000) Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21(16):1659–1668CrossRefPubMedGoogle Scholar
  4. 4.
    Kaerger JS, Edge S, Price R (2004) Influence of particle size and shape on flowability and compactibility of binary mixtures of Paracetamol and microcrystalline cellulose. Eur J Pharm Sci 22:173–179CrossRefPubMedGoogle Scholar
  5. 5.
    Vankeirsbilck T, Vercauteren A, Baeyens W, Van der Weken G (2002) Applications of Raman spectroscopy in pharmaceutical analysis. Trends Anal Chem 21(12):869–877CrossRefGoogle Scholar
  6. 6.
    Chalmers JM, Edwards HGM, Hargreaves MD (eds) (2012) Infrared and Raman spectroscopy in forensic science. Wiley, West Sussex, UKGoogle Scholar
  7. 7.
    Malvern Instruments (2009) Inform: morphologically directed chemical identification—coupling particle characterization by morphological imaging with Raman spectroscopy. Malvern Instruments, Malvern, UKGoogle Scholar
  8. 8.
    Zona C (2006) The development of a protocol for the microscopical analysis of white powder unknowns: from the hot zone to the microscope. Microsc Microanal 12:16–17CrossRefGoogle Scholar
  9. 9.
    Hargreaves M, Page K, Munshi T, Tomsett R, Lynch G, Edwards HGM (2008) Analysis of seized drugs using portable Raman spectroscopy in an airport environment—a proof of principle study. J Raman Spectrosc 39:873–880CrossRefGoogle Scholar
  10. 10.
    Ferrari A, Meyer JC, Scardaci V, Casiraghi C, Lazzeri M, Mauri F, Piscanec S, Jiang D, Novoselov KS, Roth S, Geim AK (2006) Raman spectrum of graphene and graphene layers. Phys Rev Lett 97:1–4Google Scholar
  11. 11.
    The Drug Quality and Security Act (H.R. 3204) (2013) Section 202 of the Food, Drug & Cosmetic Act. Pharmaceutical distribution supply chain. Public Law 113-54, 113th congressGoogle Scholar
  12. 12.
    Vardakou I, Pistos C, Spiliopoulou C (2011) Drugs for youth via internet and the example of mephedrone. Toxicol Lett 201:191–195CrossRefPubMedGoogle Scholar
  13. 13.
    Miotto K, Striebel J, Cho A, Wang C (2013) Clinical and pharmacological aspects of bath salt use: a review of literature and case reports. Drug Alcohol Depend 132:1–12CrossRefPubMedGoogle Scholar
  14. 14.
    Every-Palmer S (2011) Synthetic cannabinoid JWH-018 and psychosis: an explorative study. Drug Alcohol Depend 117:152–157CrossRefPubMedGoogle Scholar
  15. 15.
    Thornton S, Gerona R, Tomaszewski C (2012) Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J Med Toxicol 8:310–313CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Matousek P, Parker A (2006) Bulk Raman analysis of pharmaceutical tablets. Appl Spectrosc 60:1353–1357CrossRefPubMedGoogle Scholar
  17. 17.
    Leary PE (2014) Counterfeiting: a challenge to forensic science, the criminal justice system, and its impact on pharmaceutical innovation. Dissertation, CUNY Graduate CenterGoogle Scholar
  18. 18.
    Malvern Instruments, Ltd (2015) Component specific particle characterization of the active components in pharmaceutical topical formulations. Malvern Instruments, Malvern, UK, pp 1–4Google Scholar
  19. 19.
    Drug Enforcement Administration (2015) DEA issues nationwide alert on fentanyl as threat to health and public safety. Available via US Department of Justice. https://www.dea.gov/divisions/hq/2015/hq031815.shtml. Accessed 01 Oct 2016
  20. 20.
    Muenter M, Sharpless N, Tyce G, Darley F (1977) Patterns of dystonia (“I-D-I” and “D-I-D”) in response to l-dopa therapy for Parkinson’s disease. Mayo Clin Proc 52:163–174PubMedGoogle Scholar
  21. 21.
    Angrist B, Gershon S (1976) Clinical effects of ampetamine and L-DOPA on sexuality and aggression. Compr Psychiatry 17:715–722CrossRefPubMedGoogle Scholar
  22. 22.
    Coppola M, Mondola R (2012) Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse markted as “bath salts” or “plant food”. Toxicol Lett 211:144–149CrossRefPubMedGoogle Scholar
  23. 23.
    Dean B, Stellpflug S, Burnett A, Engebretsen K (2013) 2C or not 2C: phenethylamine designer drug review. J Med Toxicol 9:172–178CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lociciro P, Esseiva P, Hayoz P, Dujourdy L, Besacier F, Margot P (2007) Cocaine profiling for strategic intelligence purposes, a cross border project between France and Switzerland: part 1. Optimisation and harmonisation of the profiling methods. Forensic Sci Int 167:220–228CrossRefPubMedGoogle Scholar
  25. 25.
    Theerakulpisut P, Gunnula W (2012) Exogenous soribitol and trehalose mitagated salt stress damage in salt-sensitive but not salt-tolerant rice seedlings. Asian J Crop Sci 4:165–170CrossRefGoogle Scholar
  26. 26.
    Lowenthal W (1972) Disintegration of tablets. J Pharm Sci 61:1695–1711CrossRefPubMedGoogle Scholar
  27. 27.
    Jarosz PJ, Parrot EL (1984) Effect of lubricants on tensile strengths of tablets. Drug Dev Ind Pharm 10:259–273CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Andrew C. Koutrakos
    • 1
  • Pauline E. Leary
    • 1
  • Brooke W. Kammrath
    • 1
    Email author
  1. 1.Forensic Science Department, Henry C. Lee College of Criminal Justice and Forensic SciencesUniversity of New HavenWest HavenUSA

Personalised recommendations